Covered recipient · General Payments record
MITCHELL B BERGER
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Urogynecology and Reconstructive Pelvic Surgery
General Payments · PY2019–2025
$2,419.36
- Reported across 77 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $345.82 | 15 |
| Consulting Fee | $158.00 | 1 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $230.00 | 10 |
| Sentynl Therapeutics, Inc. | $158.00 | 1 |
| Sumitomo Pharma America, Inc. | $74.49 | 3 |
| Astellas Pharma US Inc | $41.33 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.65 | 02/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201504348 | CMS |
| ABBVIE INC. | $25.67 | 03/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201504350 | CMS |
| ABBVIE INC. | $25.75 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201504352 | CMS |
| ABBVIE INC. | $24.87 | 05/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201504354 | CMS |
| ABBVIE INC. | $24.94 | 07/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201504356 | CMS |
| ABBVIE INC. | $24.12 | 08/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201504358 | CMS |
| ABBVIE INC. | $22.37 | 09/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201504360 | CMS |
| ABBVIE INC. | $26.63 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201504362 | CMS |
| ABBVIE INC. | $24.98 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201504364 | CMS |
| ABBVIE INC. | $7.02 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201504366 | CMS |
| Astellas Pharma US Inc | $20.72 | 02/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238750532 | CMS |
| Astellas Pharma US Inc | $20.61 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238591416 | CMS |
| Sentynl Therapeutics, Inc. | $158.00 | 06/24/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1238881007 | CMS |
| Sumitomo Pharma America, Inc. | $28.54 | 04/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176602265 | CMS |
| Sumitomo Pharma America, Inc. | $25.08 | 09/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176602270 | CMS |
| Sumitomo Pharma America, Inc. | $20.87 | 10/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176602273 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.